We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 110

Third Circuit remands class certification ruling in blood reagents price-fixing case
  • McDermott Will & Emery
  • USA
  • April 15 2015

On Wednesday, April 8, 2015, the Third Circuit Court of Appeals vacated a district court’s order certifying a class of direct purchasers of blood


Federal judge puts narcolepsy drug horizontal conspiracy claims to bed
  • McDermott Will & Emery
  • USA
  • June 27 2014

On Monday, June 23, 2014, a Federal Judge in the Eastern District of Pennsylvania granted summary judgment for five pharmaceutical companies on


Ninth Circuit affirms divestiture of consummated physician practice acquisition
  • McDermott Will & Emery
  • USA
  • February 27 2015

The U.S. Court of Appeals for the Ninth Circuit affirmed an Idaho federal district court’s decision ordering the divestiture of a physician practice


Contractual duty to deal does not equal antitrust duty to deal
  • McDermott Will & Emery
  • USA
  • July 30 2014

Addressing for the first time whether a patent holder under a contractual duty to deal is also subject to an antitrust duty to deal, the U. S. Court


Focus on regulatory law - July 2014
  • McDermott Will & Emery
  • France
  • July 16 2014

Having been notified of an appeal against the Competition Authority’s decision regarding a joint acquisition of retail trade warehouses, the Conseil


“Reverse payment” settlements face greater antitrust scrutiny following U.S. Supreme Court ruling in FTC v. Actavis
  • McDermott Will & Emery
  • USA
  • July 31 2013

Resolving a split among the U.S. Courts of Appeals, the U.S. Supreme Court ruled that patent infringement settlement agreements between branded and


Sham-wow! antitrust liability may attach to sham administrative petitions
  • McDermott Will & Emery
  • USA
  • October 1 2014

Addressing whether the “sham” exception to Noerr-Pennington immunity is limited to sham litigation in courts, the U.S. Court of Appeals for the


North Carolina Dental Board urges reversal of FTC’s “radical” stance on state action immunity
  • McDermott Will & Emery
  • USA
  • September 5 2014

North Carolina's State Board of Dental Examiners has urged the U.S. Supreme Court to reject the Federal Trade Commission's (FTC's) "radical


Focus on regulatory law - October 2014
  • McDermott Will & Emery
  • France
  • October 3 2014

The applicant claimed that the provisions of I, Article L. 430-8 of the French Commercial Code, which allows the Competition Authority to fine


Court certifies class in hospital merger antitrust lawsuit
  • McDermott Will & Emery
  • USA
  • December 19 2013

On December 10, 2013, Judge Edmond Chang of the Northern District of Illinois certified a class of plaintiffs who filed a proposed class action